
    
      This is a prospective, multicentre, open label, randomized controlled, non-inferiority trial
      (RCT) with a 1:1 randomization to alcohol septal ablation or surgical septal myectomy in
      patients with hypertrophic obstructive cardiomyopathy (HOCM) between 40-75 year of age with
      symptoms and/or syncope due to HOCM despite medical therapy. A total of 100 patients will be
      included. All patients will be evaluated with bicycle ergometry exercise test, MRI and
      2D-echo before and 1 year after invasive treatment. Follow-up will be at 1,3 and 5 years.
    
  